Anti-inflammatory Steroids in the Prevention of Tooth Sensitivity
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Clinical randomized, triple-blind, used to measure the level of tooth sensitivity on
volunteers using a modified virtual analog scale (VAS). Sixty-six volunteers will be selected
and recruited, following inclusion criteria and pre-established exclusion. All volunteers
will be guided and sign a term of clarification and consent. Volunteers will be randomly
divided into two groups: the control group to receive placebo capsules and application of
desensitizing gel containing 6% potassium nitrate and 0.10% fluoro- (conventional treatment)
and the experimental group will receive the anti-inflammatory corticosteroids (dexamethasone,
capsule - 8mg) and application of a placebo gel. Patients will be treated in two clinical
sessions with an interval of 7 days (one week) between them. The protocol for use of the
product is as follows: The volunteers in the experimental group will receive six capsules of
dexamethasone 8 mg each to be administered orally, initially two days before the first
bleaching query as follows: 8 mg (1 capsule) 9 am in the morning two days before the first
clinical session whitening; 8 mg (1 capsule) the 9 am to 1 day before the first practice
session whitening, 8 mg (1 capsule) to 9 am on the day of the first practice session of
whitening. After 7 days (one week), the same protocol will be held for the second and final
practice session office bleaching.